| scholarly article | Q13442814 |
| P2093 | author name string | Jerome A. Roth | |
| P2860 | cites work | PINK1 is selectively stabilized on impaired mitochondria to activate Parkin | Q21145802 |
| Parkinson's disease: from monogenic forms to genetic susceptibility factors | Q22242870 | ||
| The synaptic pathology of alpha-synuclein aggregation in dementia with Lewy bodies, Parkinson's disease and Parkinson's disease dementia | Q22252705 | ||
| Human NRAMP2/DMT1, which mediates iron transport across endosomal membranes, is localized to late endosomes and lysosomes in HEp-2 cells | Q22253465 | ||
| Mitochondrial dysfunction and loss of Parkinson's disease-linked proteins contribute to neurotoxicity of manganese-containing welding fumes | Q23916368 | ||
| VPS35 mutations in Parkinson disease | Q35103751 | ||
| Part I: parkin-associated proteins and Parkinson's disease. | Q35157619 | ||
| Mutant Atp13a2 proteins involved in parkinsonism are degraded by ER-associated degradation and sensitize cells to ER-stress induced cell death | Q35175069 | ||
| Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case-control study | Q35525896 | ||
| Mutations in SLC30A10 Cause Parkinsonism and Dystonia with Hypermanganesemia, Polycythemia, and Chronic Liver Disease | Q35843237 | ||
| Manganese-induced toxicity in normal and human B lymphocyte cell lines containing a homozygous mutation in parkin. | Q36223221 | ||
| 15-Deoxy-Δ12,14-prostaglandin J2 modulates manganese-induced activation of the NF-κB, Nrf2, and PI3K pathways in astrocytes | Q36228805 | ||
| A multi-centre clinico-genetic analysis of the VPS35 gene in Parkinson disease indicates reduced penetrance for disease-associated variants | Q36370223 | ||
| Isoform specific regulation of divalent metal (ion) transporter (DMT1) by proteasomal degradation | Q36383567 | ||
| Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal | Q36455215 | ||
| Parkin is activated by PINK1-dependent phosphorylation of ubiquitin at Ser65 | Q24292901 | ||
| Ubiquitin is phosphorylated by PINK1 to activate parkin | Q24296532 | ||
| Parkin mediates nonclassical, proteasomal-independent ubiquitination of synphilin-1: implications for Lewy body formation | Q24296620 | ||
| PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1 | Q24297155 | ||
| LRRK2 kinase activity regulates synaptic vesicle trafficking and neurotransmitter release through modulation of LRRK2 macro-molecular complex | Q24298891 | ||
| LRRK2 controls an EndoA phosphorylation cycle in synaptic endocytosis | Q24299176 | ||
| LRRK2 and the stress response: interaction with MKKs and JNK-interacting proteins | Q24300440 | ||
| Pathogenic effects of novel mutations in the P-type ATPase ATP13A2 (PARK9) causing Kufor-Rakeb syndrome, a form of early-onset parkinsonism | Q24301367 | ||
| Mitochondrial localization of the Parkinson's disease related protein DJ-1: implications for pathogenesis | Q24304952 | ||
| Syndrome of hepatic cirrhosis, dystonia, polycythemia, and hypermanganesemia caused by mutations in SLC30A10, a manganese transporter in man | Q24305355 | ||
| Previously uncharacterized isoforms of divalent metal transporter (DMT)-1: implications for regulation and cellular function | Q24306074 | ||
| DJ-1 has a role in antioxidative stress to prevent cell death | Q24306633 | ||
| Parkin, PINK1, and DJ-1 form a ubiquitin E3 ligase complex promoting unfolded protein degradation | Q24312713 | ||
| Phosphorylation of parkin by Parkinson disease-linked kinase PINK1 activates parkin E3 ligase function and NF-kappaB signaling | Q24313304 | ||
| Inactivation of Pink1 Gene in Vivo Sensitizes Dopamine-producing Neurons to 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and Can Be Rescued by Autosomal Recessive Parkinson Disease Genes, Parkin or DJ-1 | Q24315046 | ||
| RAB7L1 interacts with LRRK2 to modify intraneuronal protein sorting and Parkinson's disease risk | Q24315688 | ||
| Parkin is recruited selectively to impaired mitochondria and promotes their autophagy | Q24317471 | ||
| Localization of LRRK2 to membranous and vesicular structures in mammalian brain | Q24318643 | ||
| The Parkinson disease-associated protein kinase LRRK2 exhibits MAPKKK activity and phosphorylates MKK3/6 and MKK4/7, in vitro | Q24322792 | ||
| Mitochondrial localization of DJ-1 leads to enhanced neuroprotection | Q24324226 | ||
| LRRK2 regulates synaptic vesicle endocytosis | Q24336523 | ||
| Identification of novel ATP13A2 interactors and their role in α-synuclein misfolding and toxicity | Q24337043 | ||
| Hereditary early-onset Parkinson's disease caused by mutations in PINK1 | Q24337084 | ||
| PINK1 protein in normal human brain and Parkinson's disease | Q24337151 | ||
| Down-regulation of LRRK2 in control and DAT transfected HEK cells increases manganese-induced oxidative stress and cell toxicity | Q24339471 | ||
| Retromer | Q24632869 | ||
| A mutation in VPS35, encoding a subunit of the retromer complex, causes late-onset Parkinson disease | Q24633417 | ||
| The genetics and neuropathology of Parkinson's disease | Q26859945 | ||
| Cellular function and pathological role of ATP13A2 and related P-type transport ATPases in Parkinson's disease and other neurological disorders | Q27003886 | ||
| PINK1-Parkin pathway activity is regulated by degradation of PINK1 in the mitochondrial matrix | Q27316288 | ||
| Tissue- and cell-specific mitochondrial defect in Parkin-deficient mice | Q27323332 | ||
| Structure of the ROC domain from the Parkinson's disease-associated leucine-rich repeat kinase 2 reveals a dimeric GTPase | Q27649733 | ||
| α-Synuclein in Lewy bodies | Q27860680 | ||
| Parkinson's disease-linked human PARK9/ATP13A2 maintains zinc homeostasis and promotes α-Synuclein externalization via exosomes | Q27932080 | ||
| Alpha-synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicity | Q27934988 | ||
| Zn²⁺ dyshomeostasis caused by loss of ATP13A2/PARK9 leads to lysosomal dysfunction and alpha-synuclein accumulation | Q28116171 | ||
| ATP13A2 regulates mitochondrial bioenergetics through macroautophagy | Q28116275 | ||
| Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase | Q28116395 | ||
| PARK9-associated ATP13A2 localizes to intracellular acidic vesicles and regulates cation homeostasis and neuronal integrity | Q28117134 | ||
| ATP13A2 (PARK9) polymorphisms influence the neurotoxic effects of manganese | Q28118761 | ||
| Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology | Q28131833 | ||
| LRRK2 in Parkinson's disease: protein domains and functional insights | Q28235024 | ||
| Translation initiator EIF4G1 mutations in familial Parkinson disease | Q28247679 | ||
| X-ray fluorescence imaging: a new tool for studying manganese neurotoxicity | Q28391189 | ||
| Manganese exposure induces α-synuclein aggregation in the frontal cortex of non-human primates | Q28397442 | ||
| Loss of leucine-rich repeat kinase 2 causes impairment of protein degradation pathways, accumulation of alpha-synuclein, and apoptotic cell death in aged mice | Q28507051 | ||
| Carboxyl-terminus determinants of the iron transporter DMT1/SLC11A2 isoform II (-IRE/1B) mediate internalization from the plasma membrane into recycling endosomes | Q28594427 | ||
| Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system | Q28594502 | ||
| Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: The PDGene database | Q29417106 | ||
| Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin | Q29547423 | ||
| LRRK2 phosphorylates moesin at threonine-558: characterization of how Parkinson's disease mutants affect kinase activity | Q29615144 | ||
| Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin | Q29615684 | ||
| PINK1 stabilized by mitochondrial depolarization recruits Parkin to damaged mitochondria and activates latent Parkin for mitophagy | Q29616005 | ||
| Mitochondrial pathology and muscle and dopaminergic neuron degeneration caused by inactivation of Drosophila Pink1 is rescued by Parkin | Q29617063 | ||
| PINK1 phosphorylates ubiquitin to activate Parkin E3 ubiquitin ligase activity | Q29617292 | ||
| Retrograde transport from endosomes to the trans-Golgi network | Q29617826 | ||
| PINK1-dependent recruitment of Parkin to mitochondria in mitophagy | Q29620567 | ||
| Loss-of-function of human PINK1 results in mitochondrial pathology and can be rescued by parkin | Q29622838 | ||
| R1441C mutation in LRRK2 impairs dopaminergic neurotransmission in mice. | Q30483115 | ||
| Manganese exposure induces microglia activation and dystrophy in the substantia nigra of non-human primates. | Q30498692 | ||
| Dystonia with brain manganese accumulation resulting from SLC30A10 mutations: a new treatable disorder | Q30540080 | ||
| Dopamine transporter density is decreased in parkinsonian patients with a history of manganese exposure: what does it mean? | Q30703259 | ||
| Manganese efflux in Parkinsonism: Insights from newly characterized SLC30A10 mutations | Q36675326 | ||
| Mitochondrial import and accumulation of alpha-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain | Q36727241 | ||
| Manganese intoxication in the rhesus monkey: a clinical, imaging, pathologic, and biochemical study | Q36797290 | ||
| Reduced uptake of FDOPA PET in end-stage liver disease with elevated manganese levels | Q36817049 | ||
| Modulation of cholinergic systems by manganese | Q36962713 | ||
| α-Synuclein and Mitochondria: Partners in Crime? | Q36983221 | ||
| Identification of compounds that inhibit the kinase activity of leucine-rich repeat kinase 2. | Q37079316 | ||
| Clinical genetics of Parkinson's disease and related disorders | Q37082011 | ||
| Divergent α-synuclein solubility and aggregation properties in G2019S LRRK2 Parkinson's disease brains with Lewy Body pathology compared to idiopathic cases | Q37119983 | ||
| Alterations in corticostriatal synaptic plasticity in mice overexpressing human alpha-synuclein | Q37161459 | ||
| The Role of Autophagy Dysregulation in Manganese-Induced Dopaminergic Neurodegeneration | Q37203809 | ||
| LRRK2 and neurodegeneration | Q37368006 | ||
| Molecular basis of Parkinson's disease | Q37371563 | ||
| Mitochondrial trafficking of APP and alpha synuclein: Relevance to mitochondrial dysfunction in Alzheimer's and Parkinson's diseases | Q37556779 | ||
| Are there common biochemical and molecular mechanisms controlling manganism and parkisonism | Q37598121 | ||
| Leucine-rich repeat kinase 2 and alpha-synuclein: intersecting pathways in the pathogenesis of Parkinson's disease? | Q37829776 | ||
| Genetic characteristics of leucine-rich repeat kinase 2 (LRRK2) associated Parkinson's disease | Q37884907 | ||
| Quantitative assessment of the effect of LRRK2 exonic variants on the risk of Parkinson's disease: a meta-analysis | Q38009093 | ||
| Involvement and interplay of Parkin, PINK1, and DJ1 in neurodegenerative and neuroinflammatory disorders | Q38017793 | ||
| Alpha-synuclein: from secretion to dysfunction and death | Q38028819 | ||
| The remarkable conformational plasticity of alpha-synuclein: blessing or curse? | Q38104514 | ||
| The Association Between ß-Glucocerebrosidase Mutations and Parkinsonism | Q38118169 | ||
| Manganese neurotoxicity: a focus on glutamate transporters | Q38182773 | ||
| LRRK2 and neuroinflammation: partners in crime in Parkinson's disease? | Q38198207 | ||
| Expression of the 1B isoforms of divalent metal transporter (DMT1) is regulated by interaction of NF-Y with a CCAAT-box element near the transcription start site | Q38305267 | ||
| Parkin uses the UPS to ship off dysfunctional mitochondria | Q38596770 | ||
| The Vps35 D620N mutation linked to Parkinson's disease disrupts the cargo sorting function of retromer | Q39072935 | ||
| Genetic risk for Parkinson's disease correlates with alterations in neuronal manganese sensitivity between two human subjects | Q39253264 | ||
| ROS-dependent regulation of Parkin and DJ-1 localization during oxidative stress in neurons. | Q39300846 | ||
| α-Synuclein aggregation and transmission are enhanced by leucine-rich repeat kinase 2 in human neuroblastoma SH-SY5Y cells | Q39514955 | ||
| α-Synuclein overexpression enhances manganese-induced neurotoxicity through the NF-κB-mediated pathway | Q39574142 | ||
| DJ-1 protects against dopamine toxicity | Q39922909 | ||
| RNA interference of LRRK2-microarray expression analysis of a Parkinson's disease key player | Q40032027 | ||
| Altered cleavage and localization of PINK1 to aggresomes in the presence of proteasomal stress | Q40262236 | ||
| Post-translational and transcriptional regulation of DMT1 during P19 embryonic carcinoma cell differentiation by retinoic acid | Q40360753 | ||
| Parkinsonism due to Manganism in a Welder | Q30882102 | ||
| Welding-related parkinsonism: clinical features, treatment, and pathophysiology | Q31810965 | ||
| Analysis of targeted mutation in DJ-1 on cellular function in primary astrocytes | Q33390827 | ||
| PINK1 defect causes mitochondrial dysfunction, proteasomal deficit and alpha-synuclein aggregation in cell culture models of Parkinson's disease | Q33412371 | ||
| Leucine-rich repeat kinase 2 regulates the progression of neuropathology induced by Parkinson's-disease-related mutant alpha-synuclein. | Q33594388 | ||
| Progression of dopaminergic dysfunction in a LRRK2 kindred: a multitracer PET study | Q33668068 | ||
| Release of long-range tertiary interactions potentiates aggregation of natively unstructured alpha-synuclein | Q33817987 | ||
| Immunohistochemical and subcellular localization of Parkin protein: absence of protein in autosomal recessive juvenile parkinsonism patients | Q33861614 | ||
| Homeostatic and toxic mechanisms regulating manganese uptake, retention, and elimination | Q33995229 | ||
| Mutant LRRK2 enhances glutamatergic synapse activity and evokes excitotoxic dendrite degeneration | Q34086842 | ||
| Regulation of Intracellular Manganese Homeostasis by Kufor-Rakeb Syndrome-associated ATP13A2 Protein | Q34197130 | ||
| In vivo manganese exposure modulates Erk, Akt and Darpp-32 in the striatum of developing rats, and impairs their motor function | Q34200391 | ||
| The role of the Parkinson's disease gene PARK9 in essential cellular pathways and the manganese homeostasis network in yeast | Q34212205 | ||
| Impaired Inflammatory Responses in Murine Lrrk2-Knockdown Brain Microglia | Q34230271 | ||
| The G2019S pathogenic mutation disrupts sensitivity of leucine-rich repeat kinase 2 to manganese kinase inhibition | Q34236070 | ||
| Common Pathogenic Effects of Missense Mutations in the P-Type ATPase ATP13A2 (PARK9) Associated with Early-Onset Parkinsonism | Q34286404 | ||
| 1B/(-)IRE DMT1 expression during brain ischemia contributes to cell death mediated by NF-κB/RelA acetylation at Lys310 | Q34292783 | ||
| PINK1 drives Parkin self-association and HECT-like E3 activity upstream of mitochondrial binding | Q34322599 | ||
| Loss of DJ-1 Does Not Affect Mitochondrial Respiration but Increases ROS Production and Mitochondrial Permeability Transition Pore Opening | Q34336431 | ||
| Characterization of the P5 subfamily of P-type transport ATPases in mice | Q34350143 | ||
| DJ-1 acts in parallel to the PINK1/parkin pathway to control mitochondrial function and autophagy | Q34399382 | ||
| Snaring the function of alpha-synuclein | Q34465204 | ||
| The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization | Q34836156 | ||
| Human leukocyte antigen variation and Parkinson's disease | Q35028251 | ||
| Direct Membrane Association Drives Mitochondrial Fission by the Parkinson Disease-associated Protein α-Synuclein | Q35063363 | ||
| LRRK2 modulates vulnerability to mitochondrial dysfunction in Caenorhabditis elegans | Q35080550 | ||
| α-Synuclein, leucine-rich repeat kinase-2, and manganese in the pathogenesis of parkinson disease | Q35100189 | ||
| Effect of overexpression of wild-type or mutant parkin on the cellular response induced by toxic insults | Q40380055 | ||
| Association of DJ-1 and parkin mediated by pathogenic DJ-1 mutations and oxidative stress | Q40496111 | ||
| Parkin attenuates manganese-induced dopaminergic cell death | Q40547152 | ||
| alpha-Synuclein selectively increases manganese-induced viability loss in SK-N-MC neuroblastoma cells expressing the human dopamine transporter. | Q40603357 | ||
| Expression of mutant alpha-synuclein causes increased susceptibility to dopamine toxicity | Q40844291 | ||
| The effect of manganese on dopamine toxicity and dopamine transporter (DAT) in control and DAT transfected HEK cells. | Q41876732 | ||
| Cd2+, Mn2+, Ni2+ and Se2+ toxicity to Saccharomyces cerevisiae lacking YPK9p the orthologue of human ATP13A2 | Q41899742 | ||
| Impairment of nigrostriatal dopamine neurotransmission by manganese is mediated by pre-synaptic mechanism(s): implications to manganese-induced parkinsonism | Q41951153 | ||
| Changes in GABA and glutamate concentrations during memory tasks in patients with Parkinson's disease undergoing DBS surgery. | Q42007550 | ||
| Lysosomal dysfunction in neurodegeneration: the role of ATP13A2/PARK9. | Q42321201 | ||
| The LRRK2 G2019S mutant exacerbates basal autophagy through activation of the MEK/ERK pathway | Q42509261 | ||
| Oxidative stress involvement in manganese-induced alpha-synuclein oligomerization in organotypic brain slice cultures | Q42519882 | ||
| Activation of JNK Pathway and Induction of Apoptosis by Manganese in PC12 Cells | Q42539432 | ||
| Intrastriatal manganese chloride exposure causes acute locomotor impairment as well as partial activation of substantia nigra GABAergic neurons | Q42610629 | ||
| Manganese accumulation in striatum of mice exposed to toxic doses is dependent upon a functional dopamine transporter. | Q42729792 | ||
| The case for manganese interaction with mitochondria | Q42779559 | ||
| Differential effects of divalent manganese and magnesium on the kinase activity of leucine-rich repeat kinase 2 (LRRK2). | Q43141823 | ||
| Parkin regulates metal transport via proteasomal degradation of the 1B isoforms of divalent metal transporter 1. | Q43188522 | ||
| [18F]FDOPA PET and clinical features in parkinsonism due to manganism | Q45222225 | ||
| Human alpha-synuclein over-expression increases intracellular reactive oxygen species levels and susceptibility to dopamine. | Q45711545 | ||
| Manganese accumulation in membrane fractions of primary astrocytes is associated with decreased γ-aminobutyric acid (GABA) uptake, and is exacerbated by oleic acid and palmitate | Q45722355 | ||
| Dopamine and the dopamine oxidation product 5,6-dihydroxylindole promote distinct on-pathway and off-pathway aggregation of alpha-synuclein in a pH-dependent manner | Q46053822 | ||
| Pathology of inherited manganese transporter deficiency | Q46134590 | ||
| PET in LRRK2 mutations: comparison to sporadic Parkinson's disease and evidence for presymptomatic compensation | Q46635617 | ||
| Whole blood manganese correlates with high signal intensities on T1-weighted MRI in patients with liver cirrhosis | Q48135465 | ||
| Increased vulnerability of nigrostriatal terminals in DJ-1-deficient mice is mediated by the dopamine transporter | Q48140823 | ||
| Marked N-acetylaspartate and choline metabolite changes in Parkinson's disease patients with mild cognitive impairment | Q48254809 | ||
| Alpha-synuclein induced membrane depolarization and loss of phosphorylation capacity of isolated rat brain mitochondria: implications in Parkinson's disease | Q48274235 | ||
| Nigrostriatal dopamine system dysfunction and subtle motor deficits in manganese-exposed non-human primates | Q48440122 | ||
| Neurodegenerative disease: pink, parkin and the brain | Q48482709 | ||
| Alterations in lysosomal and proteasomal markers in Parkinson's disease: relationship to alpha-synuclein inclusions | Q48581414 | ||
| Manganese and chronic liver disease | Q48932332 | ||
| Novel mutation in ATP13A2 widens the spectrum of Kufor-Rakeb syndrome (PARK9). | Q49140091 | ||
| Manganese induces oxidative impairment in cultured rat astrocytes. | Q50469431 | ||
| Intestinal DMT1 cotransporter is down-regulated by hepcidin via proteasome internalization and degradation. | Q50529592 | ||
| DJ-1 (PARK7) mutations are less frequent than Parkin (PARK2) mutations in early-onset Parkinson disease | Q51051455 | ||
| Aggregated alpha-synuclein mediates dopaminergic neurotoxicity in vivo. | Q52678048 | ||
| The role of LRRK2 in the regulation of monocyte adhesion to endothelial cells | Q54355801 | ||
| ATP13A2‐related neurodegeneration (PARK9) without evidence of brain iron accumulation | Q54598452 | ||
| Manganese induces the overexpression of α-synuclein in PC12 cells via ERK activation | Q54654107 | ||
| The role of pathogenic DJ-1 mutations in Parkinson's disease. | Q54757155 | ||
| PARK9-LINKED PARKINSONISM IN EASTERN ASIA: MUTATION DETECTION IN ATP13A2 AND CLINICAL PHENOTYPE | Q56772080 | ||
| Degradation of alpha-synuclein by proteasome | Q73195792 | ||
| Manganese-induced rat pheochromocytoma (PC12) cell death is independent of caspase activation | Q73949371 | ||
| DJ-1( PARK7), a novel gene for autosomal recessive, early onset parkinsonism | Q79249169 | ||
| DMT1: which metals does it transport? | Q83183734 | ||
| Chronic exposure to manganese decreases striatal dopamine turnover in human alpha-synuclein transgenic mice | Q83443666 | ||
| PINK1 points Parkin to mitochondria | Q84259115 | ||
| ROS-induced mitochondrial depolarization initiates PARK2/PARKIN-dependent mitochondrial degradation by autophagy | Q84788113 | ||
| Switching on ubiquitylation by phosphorylating a ubiquitous activator | Q87970816 | ||
| P6195 | funding scheme | grant | Q230788 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | gene | Q7187 |
| metabolic pathway | Q68685 | ||
| manufacturing | Q187939 | ||
| manganese | Q731 | ||
| Parkinson's disease | Q11085 | ||
| toxicology | Q7218 | ||
| protein | Q8054 | ||
| P5008 | on focus list of Wikimedia project | Wikimedia–NIOSH collaboration | Q104416361 |
| P304 | page(s) | 314-325 | |
| P12526 | performing organization | University at Buffalo | Q681025 |
| P577 | publication date | 2014-09-01 | |
| P1433 | published in | NeuroToxicology | Q15098069 |
| P859 | sponsor | National Institute for Occupational Safety and Health | Q60346 |
| P1476 | title | Correlation between the biochemical pathways altered by mutated Parkinson-related genes and chronic exposure to manganese | |
| P478 | volume | 44 |
| Q21131066 | Beneficial effects of nicotine, cotinine and its metabolites as potential agents for Parkinson's disease |
| Q38915163 | Coherent and Contradictory Facts, Feats and Fictions Associated with Metal Accumulation in Parkinson's Disease: Epicenter or Outcome, Yet a Demigod Question |
| Q36179612 | Involvement of heat shock proteins on Mn-induced toxicity in Caenorhabditis elegans |
| Q42510777 | Manganese exposure exacerbates progressive motor deficits and neurodegeneration in the MitoPark mouse model of Parkinson's disease: Relevance to gene and environment interactions in metal neurotoxicity |
| Q40116195 | Manganese transporter Slc39a14 deficiency revealed its key role in maintaining manganese homeostasis in mice |
| Q91781230 | Manganese-Induced Neurotoxicity: New Insights Into the Triad of Protein Misfolding, Mitochondrial Impairment, and Neuroinflammation |
| Q47147993 | Mitochondria: A Common Target for Genetic Mutations and Environmental Toxicants in Parkinson's Disease |
| Q27316540 | Mutations in SLC39A14 disrupt manganese homeostasis and cause childhood-onset parkinsonism-dystonia |
| Q37023627 | NAD+ Supplementation Attenuates Methylmercury Dopaminergic and Mitochondrial Toxicity in Caenorhabditis Elegans |
| Q44876091 | Neonatal C57BL/6J and parkin mice respond differently following developmental manganese exposure: Result of a high dose pilot study. |
| Q54381681 | PINK1 and the related diseases |
| Q99585310 | Phenotypic assays in yeast and zebrafish reveal drugs that rescue ATP13A2 deficiency |
| Q47784247 | Recent Advances in the Role of SLC39A/ZIP Zinc Transporters In Vivo |
| Q39043644 | Role of neurotoxicants and traumatic brain injury in α-synuclein protein misfolding and aggregation. |
| Q50043374 | SLC39A14 deficiency alters manganese homeostasis and excretion resulting in brain manganese accumulation and motor deficits in mice. |
| Q51275277 | The dual enzyme LRRK2 hydrolyzes GTP in both its GTPase and kinase domains in vitro |
| Q26740340 | Untangling the Manganese-α-Synuclein Web |
| Q40141578 | Zebrafish slc30a10 deficiency revealed a novel compensatory mechanism of Atp2c1 in maintaining manganese homeostasis |
Search more.